Mercer Global Advisors Inc Dr Reddys Laboratories LTD Transaction History
Mercer Global Advisors Inc
- $43 Billion
- Q1 2025
A detailed history of Mercer Global Advisors Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Mercer Global Advisors Inc holds 25,808 shares of RDY stock, worth $400,798. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,808
Previous 27,419
5.88%
Holding current value
$400,798
Previous $432,000
21.3%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RDY
# of Institutions
263Shares Held
98.8MCall Options Held
12.5KPut Options Held
800-
Robeco Institutional Asset Management B.V.10.7MShares$166 Million0.28% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.2MShares$143 Million0.19% of portfolio
-
Royal Bank Of Canada Toronto, A69.05MShares$141 Million0.03% of portfolio
-
Morgan Stanley New York, NY8.74MShares$136 Million0.01% of portfolio
-
Aikya Investment Management LTD London, X06.2MShares$96.3 Million30.32% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.58B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...